lactic acid has been researched along with artenimol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Li, B; Ma, W; Xu, A; Ying, J | 1 |
| Lu, J; Sun, L; Wang, L; Wang, X; Wang, Y; Zheng, Y; Zhou, Z | 1 |
| Gao, P; Gu, L; Li, X; Liu, D; Liu, Y; Luo, P; Meng, Y; Shen, S; Zhang, J; Zhu, Y | 1 |
3 other study(ies) available for lactic acid and artenimol
| Article | Year |
|---|---|
Biodegradable Core-Shell Copolymer-Phospholipid Nanoparticles for Combination Chemotherapy: An In Vitro Study.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Absorbable Implants; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Nucleus; Cell Survival; Diffusion; Doxorubicin; Drug Implants; HeLa Cells; Hep G2 Cells; Humans; Lactic Acid; Nanocapsules; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome | 2015 |
Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity.
Topics: Artemisinins; Drug Carriers; Hep G2 Cells; Humans; Lactic Acid; Nanoparticles; Phospholipids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
Topics: Artemisinins; Carrier Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Glycolysis; Hep G2 Cells; Humans; K562 Cells; Lactic Acid; Membrane Proteins; RNA, Messenger; Structure-Activity Relationship; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2020 |